Insulin action in hyperthyroidism: A focus on muscle and adipose tissue

Endocrine Reviews

Volumn 31, Issue 5, 2010, Pages 663-679

  Mitrou, Panayota ^a   Raptis, Sotirios A ^a,b   Dimitriadis, George ^b  

^a Hellenic National Center for the Research   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO ACID; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; INTERLEUKIN 6; LACTIC ACID; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; BLOOD FLOW; CYTOKINE PRODUCTION; GLUCONEOGENESIS; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; INSULIN RELEASE; INTESTINE ABSORPTION; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; NONHUMAN; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SKELETAL MUSCLE; STOMACH EMPTYING;

ADIPOSE TISSUE; ANIMALS; GLUCOSE; HUMANS; HYPERTHYROIDISM; INSULIN; LIPID METABOLISM; MUSCLE, SKELETAL;

EID: 77958154730     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0046     Document Type: Review

References (177)

1. Dimitriadis G, Raptis SA 2001 Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109(Suppl 2):S225-S239 (Pubitemid 32586073)
2. Potenza M, Via MA, Yanagisawa RT 2009 Excess thyroid hormone and carbohydrate metabolism. Endocr Pract 15:254-262
3. Kim SR, Tull ES, Talbott EO, Vogt MT, Kuller LH 2002 A hypothesis of synergism: the interrelatioship of T3 and insulin to disturbances in metabolic homeostasis. Med Hypotheses 59:660-666 (Pubitemid 35463451)
4. Althausen T, Stockholm M 1938 Influence of thyroid gland on absorption in digestive tract. Am J Physiol 123:577-588
5. Holdsworth C, Besser G 1968 Influence of gastric emptying rate and of insulin response on oral glucose tolerance in thyroid disease. Lancet 2:700-702
6. Ikeda T, Fujiyama K, Hoshino T, Takeuchi T, Tominaga M, Mashiba H 1989 Glucose tolerance and gastric emptying in thyrotoxic rats. Metabolism 38:874-877 (Pubitemid 19229966)
7. Pfaffenbach B, Adamek RJ, Hagelmann D, Schaffstein J, Wegener M 1997 Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. Hepatogastroenterology 44:1500-1508 (Pubitemid 27450203)
8. Barczyñski M, Thor P 2001 Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying. Clin Auton Res 11:243-249 (Pubitemid 33043694)
9. Wegener M, Wedmann B, Langhoff T, Schaffstein J, Adamek R 1992 Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab 75:745-749
10. Jonderko K, Jonderko G, Marcisz C, Gołab T 1997 Gastric emptying in hyperthyroidism. Am J Gastroenterol 92:835-838
11. Kisakol G, Kayacetin E, Sari O, Kaya A 2003 Gastric emptying in subclinical hyperthyroidism. Neuro Endocrinol Lett 24:255-258
12. Dimitriadis G, Baker B, Marsh H, Mandarino L, Rizza R, Bergman R, Haymond M, Gerich J 1985 Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 248:E593-E601 (Pubitemid 15018379)
13. Müller MJ, Seitz HJ 1980 Rapid and direct stimulation of hepatic gluconeogenesis by L-triiodothyronine in the isolated perfused rat liver. Life Sci 27:827-835
14. McCulloch AJ, Nosadini R, Pernet A, Piniewska M, Cook DB, Clark F, Johnston DG, Alberti KG 1983 Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure. Clin Sci 64:41-47 (Pubitemid 13207250)
15. Bratusch-Marrain PR, Gasiæ S, Waldhäusl WK 1984 Triiodothyronine increases splachnic release and peripheral uptake of glucose in healthy human. Am J Physiol 247:E681-E687
16. Wennlund A, Felig P, Hagenfeldt L, Wahren J 1986 Hepatic glucose production and splachnic glucose exchange in hyperthyroidism. J Clin Endocrinol Metab 62:174-180 (Pubitemid 16186862)
17. Holness MJ, Sugden MC 1987 Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. Biochem J 247:801-804
18. Sestoft L, Bartels PD, Fleron P, Folke M, Gammeltoft S, Kristensen LO 1977 Influence of thyroid state on the effects of glycerol on gluconeogenesis and energy metabolism in perfused rat liver. Biochem Biophys Acta 499:119-130 (Pubitemid 8157563)
19. 3H labeled glucose. Biochem J 182:565-575
20. Okajima F, Ui M 1979 Metabolism of glucose in hyperand hypothyroid rats in vivo: minor role of endogenous insulin in thyroid-dependent changes in glucose turnover. Biochem J 182:577-584 (Pubitemid 10224863)
21. Okajima F, Ui M 1979 Metabolism of glucose in hyperand hypothyroid rats in vivo: relation of catecholamine actions to thyroid activity in controlling glucose turnover. Biochem J 182:585-592 (Pubitemid 10224864)
22. Saunders J, Hall SE, Sönksen PH 1980 Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment. Clin Endocrinol (Oxf) 13:33-44 (Pubitemid 10092945)
23. Huang MT, Lardy HA 1981 Effect of thyroid states on the Cori cycle, glucose-alanine cycle and futile cycling of glucose metabolism in rats. Arch Biochem Biophys 209:41-51
24. Müller MJ, Paschen U, Seitz HJ 1983 Thyroid hormone regulation of glucose homeostasis in the miniature pig. Endocrinology 112:2025-2031 (Pubitemid 13048647)
25. Sandler MP, Robinson RP, Rabin D, Lacy WW, Abumrad NN 1983 The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man. J Clin Endocrinol Metab 56:479-485 (Pubitemid 13157790)
26. Dimitriadis G, Newsholme EA 2004 Integration of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentration. In: LeRoith D, Taylor S, Olefsky J, eds. Diabetes mellitus, a fundamental and clinical text. 3rd ed. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott, Williams and Wilkins; 183-197
27. Kabadi U, Eisenstein A 1980 Impaired pancreatic a-cell response in hyperthyroidism. J Clin Endocrinol Metab 51:478-482 (Pubitemid 10022827)
28. Kabadi U, Eisenstein A 1980 Glucose intolerance in hyperthyroidism: role of glucagon. J Clin Endocrinol Metab 50:392-396 (Pubitemid 10161483)
29. Perez G, Ungano B, Covelli A, Morrone G, Lombardi G, Scopacasa F, Rossi R 1980 Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. J Clin Endocrinol Metab 51:972-977 (Pubitemid 11225446)
30. Madsen SN, Sonne O 1976 Increase of glucagon receptors in hyperthyroidism. Nature 262:793-795
31. Riis AL, Jørgensen JO, Ivarsen P, Frystyk J, Weeke J, Møller N 2008 Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women. J Clin Endocrinol Metab 93:3999-4005
32. Weinstein SP, O'Boyle E, Fisher M, Haber RS 1994 Regulation of GLUT 2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of hepatic glucose transport system. Endocrinology 135:649-654 (Pubitemid 24241246)
33. Mokuno T, Uchimura K, Hayashi R, Hayakawa N, Makino M, Nagata M, Kakizawa H, Sawai Y, Kotake M, Oda N, Nakai A, Nagasaka A, Itoh M 1999 Glucose transporter concentrations in hyper- and hypothyroid rat livers. J Endocrinol 160:285-289 (Pubitemid 29074699)
34. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, Tzanela M, Thalassinos N, Raptis SA 2006 Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 91:1112-1118 (Pubitemid 43357789)
35. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Barletta A, Liverini G 2001 Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats. Int J Obes Relat Metab Disord 25:417-425 (Pubitemid 32209819)
36. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, Giacca A 2003 Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284:E863-E873 (Pubitemid 36444021)
37. Klieverik LP, Janssen SF, van Riel A, Foppen E, Bisschop PH, Serlie MJ, Boelen A, Ackermans MT, Sauerwein HP, Fliers E, Kalsbeek A 2009 Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventicular nucleus to the liver. Proc Natl Acad Sci USA 106:5966-5971
38. Dimitriadis G, Parry-Billings M, Bevan S, Leighton B, Krause U, Piva T, Tegos K, Challiss RA, Wegener G, Newsholme EA 1997 The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 27:475-483 (Pubitemid 27288357)
39. Newsholme EA, Crabtree B 1976 Substrate cycles in metabolic regulation and heat generation. Biochem Soc Symp 41:61-109
40. Foss MC, Paccola GM, Saad MJ, Pimenta WP, Piccinato CE, Iazigi N 1990 Peripheral glucose metabolism in human hyperthyroidism. J Clin Endocrinol Metab 70:1167-1172 (Pubitemid 20138644)
41. Laville M, Riou JP, Bougneres PF, Canivet B, Beylot M, Cohen R, Serusclat P, Dumontet C, Berthezene F, Mornex R 1984 Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover. J Clin Endocrinol Metab 58:960-965
42. Randin JP, Scazziga B, Jéquier E, Felber JP 1985 Studies of glucose and lipid metabolism and continuous indirect calorimetry in Graves' disease: effect of an oral glucose load. J Clin Endocrinol Metab 61:1165-1171 (Pubitemid 16186720)
43. Cavallo-Perin P, Bruno A, Boine L, Cassader M, Lenti G, Pagano G 1988 Insulin resistance in Graves' disease: a quantitative in vivo evaluation. Eur J Clin Invest 18:607-613 (Pubitemid 19041527)
44. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, Panagiotakos D, Tountas N, Economopoulos T, Raptis SA 2008 Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J Clin Endocrinol Metab 93:2413-2415 (Pubitemid 351831566)
45. Dimitriadis GD, Leighton B, Vlachonikolis IG, Parry-Billings M, Challiss RA, West D, Newsholme EA 1988 Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Biochem J 253:87-92
46. Ho WJ, Chen ST, Tsay PK, Wang CL, Hsu TS, Kuo CT, Chen WJ 2007 Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism. Clin Endocrinol (Oxf) 67:505-511
47. Randin JP, Tappy L, Scazziga B, Jequier E, Felber JP 1986 Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurements by the glucose clamp technique and continuous indirect calorimetry. Diabetes 35:178-181
48. Casla A, Rovira A, Wells JA, Dohm GL 1990 Increased glucose transporter (GLUT4) protein expression in hyperthyroidism. Biochem Biophys Res Commun 171:182-188
49. Shepherd PR, Kahn BB 1999 Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248-257
50. Castelló A, Rodríguez-Manzaneque JC, Camps M, Pérez-Castillo A, Testar X, Palacín M, Santos A, Zorzano A 1994 Perinatal hypothyroidism impairs the normal transition of GLUT 4 and GLUT 1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. J Biol Chem 269:5905-5912
51. Weinstein SP, O'Boyle E, Haber RS 1994 Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle: the role of GLUT4 glucose transporter expression. Diabetes 43:1185-1189
52. Haber RS, Wilson CM, Weinstein SP, Pritsker A, Cushman SW 1995 Thyroid hormone increases the partitioning of glucose transporters to the plasma membrane in ARL 15 cells. Am J Physiol 269:E605-E610
53. Weinstein SP, Watts J, Haber RS 1991 Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. Endocrinology 129:455-464
54. Heather LC, Cole MA, Atherton HJ, Coumans WA, Evans RD, Tyler DJ, Glatz JF, Luiken JJ, Clarke K 2010 Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. Endocrinology 151:422-431
55. Dimitriadis G, Maratou E, Alevizaki M, Boutati E, Psara K, Papasteriades C, Raptis SA 2005 Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm Metab Res 37:15-20
56. Khayat ZA, McCall AL, Klip A 1998 Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand. Biochem J 333:713-718
57. Mandarino LJ, Printz RL, Cusi KA, Kinchington P, O'Doherty RM, Osawa H, Sewell C, Consoli A, Granner DK, DeFronzo RA 1995 Regulation of hexokinase II and glycogen synthase mRNA protein, and activity in human muscle. Am J Physiol 269:E701-E708
58. Sugden MC, Liu YL, Holness MJ 1990 Glucose utilization by skeletal muscles in-vivo in experimental hyperthyroidism in the rat. Biochem J 271:421-425
59. Møller N, Nielsen S, Nyholm B, Pørksen N, Alberti KG, Weeke J 1996 Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol (Oxf) 44:453-459
60. Dimitriadis GD, Richards SJ, Parry-Billings M, Leighton B, Newsholme EA, Challiss RA 1991 β-Adrenoreceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states. Biochem J 278:587-593
61. Bachman ES, Hampton TG, Dhillon H, Amende I, Wang J, Morgan JP, Hollenberg AN 2004 The metabolic and cardiovascular effects of hyperthyroidism are independent of β-adrenergic stimulation. Endocrinology 145:2767-2774
62. Ladenson PW, Sherman SI, Baughman KL, Ray PE, Feldman AM 1992 Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89:5251-5255
63. Tse J, Wrenn RW, Kuo JF 1980 Thyroxine-induced changes in characteristics and activities of β-adrenergic receptors and adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrinology 107:6-16
64. Carvalho-Bianco SD, Kim BW, Zhang JX, Harney JW, Ribeiro RS, Gereben B, Bianco AC, Mende U, Larsen PR 2004 Chronic cardiac-specific thyrotoxicosis increases myocardial β-adrenergic responsiveness. Mol Endocrinol 18:1840-1849
65. Sugden MC, Lall HS, Harris RA, Holness MJ 2000 Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. J Endocrinol 167:339-345
66. Short KR, Nygren J, Barazzoni R, Levine J, Nair KS 2001 T3 increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and -3. Am J Physiol Endocrinol Metab 280:E761-E769
67. Short KR, Nygren J, Nair KS 2007 Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. Am J Physiol Endocrinol Metab 292:E642-E647
68. Valcavi R, Zini M, Portioli I 1992 Thyroid hormone and growth hormone secretion. J Endocrinol Invest 15:313-330
69. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R 1993 Effects of hypo- and hyperthyroidism on IGFs, growth hormone and IGF-binding proteins. J Clin Endocrinol Metab 76:950-955
70. Tosi F, Moghetti P, Castello R, Negri C, Bonora E, Muggeo M 1996 Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism 45:1029-1033
71. Rizza RA, Mandarino LJ, Gerich JE 1982 Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab 54:131-138
72. Rizza RA, Mandarino LJ, Gerich JE 1982 Effects of growth hormone on insulin action: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization. Diabetes 31:663-669
73. Ng SF, Storlien LH, Kraegen EW, Stuart MC, Chapman GE, Lazarus L 1990 Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in-vivo. Metabolism 39:264-268
74. Dimitriadis G, Parry-Billings M, Leighton B, Piva T, Dunger D, Calder P, Bond J, Newsholme E 1994 Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle. Eur J Clin Invest 24:161-165
75. Haber RS, Weinstein SP 1992 Role of glucose transporters in glucocorticoid-induced insulin resistance. Diabetes 41:728-735
76. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA 1997 Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 321:707-712 (Pubitemid 27084879)
77. Taylor R, McCulloch AJ, Zeuzem S, Gray P, Clark F, Alberti KG 1985 Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endocrinol 109:96-103
78. Hagen JH 1960 Effect of insulin on the metabolism of adipose tissue from hyperthyroid rats. J Biol Chem 235:2600-2603
79. Matthaei S, Trost B, Hamann A, Kausch C, Benecke H, Greten H, Höppner W, Klein HH 1995 Effects of in vivo thyroid hormone status on insulin signaling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes. J Endocrinol 144:347-357
80. Czech MP, Malbon CC, Kerman K, Gitomer W, Pilch PF 1980 Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle. J Clin Invest 66:574-582
81. Cech JM, Amatruda JM 1983 The effect of triiodothyronine on insulin binding and action in rat adipocytes. Horm Metab Res 15:530-532
82. Arner P, Bolinder J, Wennlund A, Ostman J 1984 Influence of thyroid hormone level on insulin action in human adipose tissue. Diabetes 33:369-375
83. Pedersen O, Richelsen B, Bak J, Arnfred J, Weeke J, Schmitz O 1988 Characterization of the insulin resistance of glucose utilization in adipocytes from patients with hyper- and hypothyroidism. Acta Endocrinol 119:228-234
84. Voldstedlund M, Tranum-Jensen J, Handberg A, Vinten J 1995 Quantity of Na/K-ATPase and glucose transporters in the plasma membrane of rat adipocytes is reduced by in vivo triiodothyronine. Eur J Endocrinol 133:626-634
85. Goto H, Sumida Y, Nakatani K, Yano Y, Shima T 1997 Effect of triiodothyronine on glucose transport in rat adipocytes. Life Sci 61:193-204
86. Fryer LG, Holness MJ, Sugden MC 1997 Selective modification of insulin action in adipose tissue by hyperthyroidism. J Endocrinol 154:513-522
87. Rich C, Bierman EL, Schwartz IL 1959 Plasma non-esterified fatty acids in hyperthyroid states. J Clin Invest 38:275-278
88. Pucci E, Chiovato L, Pinchera A 2000 Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 24(Suppl 2):109-112
89. Coppack SW, Jensen MD, Miles JM 1994 The in vivo regulation of lipolysis in humans. J Lipid Res 35:177-193
90. Frayn KN 2002 Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201-1210
91. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-1386
92. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB, Holm C, Arner P, Blaak EE 2007 Adipose triglyceride (ATGL) and hormone-sensitive lipase (HSL) protein expression is decreased in the obese insulin resistant state. J Clin Endocrinol Metab 92:2292-2299
93. Abrams JJ, Grundy SM, Ginsberg H 1981 Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism. J Lipid Res 22:307-322
94. Lam KS, Chan MK, Yeung RT 1986 High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction: effects of treatment. Q J Med 59:513-521
95. Nikkilä EA, Kekki M 1972 Plasma triglyceride metabolism in thyroid disease. J Clin Invest 51:2103-2114
96. Tulloch B, Lewis B, Fraser TR 1973 Triglyceride metabolism in thyroid disease. Lancet 1:391-394
97. Frayn KN, Shadid S, Hamlani R, Humphreys SM, Clark ML, Fielding BA, Boland O, Coppack SW 1994 Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Am J Physiol 266:E308-E317
98. Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F 2005 The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48:83-95
99. Lewis GF, Carpentier A, Adeli K, Giacca A 2002 Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229
100. Heimberg M, Olubadewo JO, Wilcox HG 1985 Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev 6:590-607
101. Miles JM, Wooldridge D, Grellner WJ, Windsor S, Isley WL, Klein S, Harris WS 2003 Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic patients. Diabetes 52:675-681
102. Jensen MD, Caruso M, Heiling V, Miles JM 1989 Insulin regulation of lipolysis in non-diabetic and IDDM subjects. Diabetes 38:1595-1601 (Pubitemid 20006686)
103. Stumvoll M, Jacob S, Wahl HG, Hauer B, Löblein K, Grauer P, Becker R, Nielsen M, Renn W, Häring H 2000 Suppression of systemic, intramuscular and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85:3740-3745
104. Riis AL, Gravholt CH, Djurhuus CB, Nørrelund H, Jørgensen JO, Weeke J, Møller N 2002 Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87:4747-4753
105. Haluzik M, Nedvidkova J, Bartak V, Dostalova I, Vlcek P, Racek P, Taus M, Svacina S, Alesci S, Pacak K 2003 Effects of hypo- and hyperthyroidism on noradrenergic activity and glycerol concentrations in human subcutaneous abdominal adipose tissue assessed with microdialysis. J Clin Endocrinol Metab 88:5605-5608 (Pubitemid 38033022)
106. Nedvidkova J, Haluzik M, Bartak V, Dostalova I, Vlcek P, Racek P, Taus M, Behanova M, Svacina S, Alesci S, Pacak K 2004 Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study. Ann NY Acad Sci 1018:541-549 (Pubitemid 38951451)
107. Cachefo A, Boucher P, Vidon C, Dusserre E, Diraison F, Beylot M 2001 Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab 86:5353-5357 (Pubitemid 33070259)
108. Beylot M, Martin C, Laville M, Riou JP, Cohen R, Mornex R 1991 Lipolytic and ketogenic fluxes in human hyperthyroidism. J Clin Endocrinol Metab 73:42-49 (Pubitemid 21901097)
109. Hagenfeldt L, Wennlung A, Felig P, Wahren J 1981 Turnover and splanchnic metabolism of free fatty acids in hyperthyroidism patients. J Clin Invest 67:1672-1677 (Pubitemid 11127558)
110. Gebhard RL, Stone BG, Andreini JP, Duane WC, Evans CD, Prigge W 1992 Thyroid hormone differentially augments biliary sterol secretion in the rat. I. The isolated perfused liver model. J Lipid Res 33:1459-1466
111. Sestoft L 1980 Metabolic aspects of the calorigenic effect of thyroid hormone in mammals. Clin Endocrinol (Oxf) 13:489-506 (Pubitemid 11225180)
112. Dimitriadis G, Boutati E, Raptis SA 2007 The importance of adipose tissue in diabetes pathophysiology and treatment. Horm Metab Res 39:705-706 (Pubitemid 350103436)
113. Rabe K, Lehrke M, Parhofer KG, Broedl UC 2008 Adipokines and insulin resistance. Mol Med 14:741-751
114. Hardardóttir I, Grünfeld C, Feingold KR 1994 Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-215 (Pubitemid 24198817)
115. Iglesias P, Alvarez Fidalgo P, Codoceo R, Díez JJ 2003 Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 59:621-629 (Pubitemid 37357624)
116. Santini F, Marsili A, Mammoli C, Valeriano R, Scartabelli G, Pelosini C, Giannetti M, Centoni R, Vitti P, Pinchera A 2004 Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest 27:RC5-RC7 (Pubitemid 38514799)
117. Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, Arslan M 2006 Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol (Oxf) 65:530-535 (Pubitemid 44414279)
118. Yaturu S, Prado S, Grimes SR 2004 Changes in adipocytes hormones leptin, resistin and adiponectin in thyroid dysfunction. J Cell Biochem 93:491-496 (Pubitemid 44264184)
119. Saito T, Kawano T, Saito T, Ikoma A, Namai K, Tamemoto H, Kawakami M, Ishikawa SE 2005 Elevation of serum adiponectin levels in Basedow disease. Metabolism 54:1461-1466
120. Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, Cianflone K 2006 Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond) 3:13
121. Sieminska L, Niedziolka D, Pillich A, Kos-Kudla B, Marek B, Nowak M, Borgiel-Marek H 2008 Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients. J Endocrinol Invest 31:745-749
122. Iglesias P, Díez JJ 2007 Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40:61-70 (Pubitemid 350180533)
123. Wahrenberg H, Wennlund A, Hoffstedt J 2002 Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumor necrosis factor α, in Graves' hyperthyroidism. Eur J Endocrinol 146:607-611 (Pubitemid 34552492)
124. Ozata M, Uckaya G, Bolu E, Corapcioglu D, Bingol N, Ozdemir IC 2001 Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy. Med Sci Monit 7:696-700 (Pubitemid 32691748)
125. Seven R 2001 Thyroid status and leptin in Basedow-Graves and multinodular goiter patients. J Toxicol Environ Health A 63:575-581 (Pubitemid 32804087)
126. Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW, Mohamed-Ali V 1998 Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf) 49:583-588
127. Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC 2006 Leptin acute modulation of the 5′-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res 38:481-485 (Pubitemid 44378787)
128. Lisboa PC, Oliveira KJ, Cabanelas A, Ortiga-Carvalho TM, Pazos-Moura CC 2003 Acute cold exposure, leptin, and somatostatin analog (octerotide) modulate thyroid 5′-deiodinase activity. Am J Physiol Endocrinol Metab 284:E1172-E1176 (Pubitemid 36617464)
129. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA 2003 Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52:2784-2789
130. Senn JJ, Klover PJ, Nowak IA, Mooney RA 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399 (Pubitemid 35403441)
131. Rotter V, Nagaev I, Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784 (Pubitemid 37432722)
132. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, Kemp BE, Pedersen BK, Febbraio MA 2006 Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55:2688-2697 (Pubitemid 44923666)
133. Al-Khalili L, Bouzakri K, Glund S, Lönnqvist F, Koistinen HA, Krook A 2006 Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20:3364-3375 (Pubitemid 44833576)
134. Salvi M, Pedrazzoni M, Girasole G, Giuliani N, Minelli R, Wall JR, Roti E 2000 Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 143:197-202 (Pubitemid 30622353)
135. Al-Humaidi MA 2000 Serum cytokine levels in Graves' disease. Saudi Med J 21:639-644
136. Mitrou P, Boutati E, Lambadiari V, Tsegka A, Raptis AE, Tountas N, Economopoulos T, Raptis SA, Dimitriadis G 2010 Insulin resistance in hyperthyroidism: the role of IL6 and TNFα. Eur J Endocrinol 162:121-126
137. Pontikides N, Krassas GE 2007 Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 17:421-431 (Pubitemid 46878845)
138. Senturk T, Kozaci LD, Kok F, Kadikoylu G, Bolaman Z 2003 Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 26:58-63
139. Celik I, Akalin S, Erbå T 1995 Serum levels of interleukin 6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 132:668-672
140. Díez JJ, Hernanz A, Medina S, Bayón C, Iglesias P 2002 Serum concentrations of tumor necrosis factor-α(TNF-α) and soluble TNF-α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf) 57:515-521 (Pubitemid 35216303)
141. Berg M, Fraker DL, Alexander HR 1994 Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 6:425-432 (Pubitemid 24263888)
142. Feingold KR, Grunfeld C 1992 Role of cytokines in inducing hyperlipidemia. Diabetes 41(Suppl 2):97-101
143. Krassas GE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Panidis D 2005 Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body composition. Eur J Endocrinol 153:217-221 (Pubitemid 41167479)
144. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
145. Tsiotra PC, Tsigos C, Yfanti E, Anastasiou E, Vikentiou M, Psarra K, Papasteriades C, Raptis SA 2007 Visfatin, TNFα and IL6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm Metab Res 39:758-763
146. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B 2006 Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91:1578-1581
147. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R 2006 Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 91:3165-3170 (Pubitemid 44271773)
148. Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC 2008 Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Metabolism 57:1380-1383
149. Ozkaya M, Sahin M, Cakal E, Yuzbasioglu F, Sezer K, Kilinc M, Imrek SS 2009 Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. J Endocrinol Invest 32:435-439
150. Hales CN, Hyams DE 1964 Plasma concentrations of glucose non-esterified fatty acid, and insulin during oral glucose tolerance tests in thyrotoxicosis. Lancet 2:69-71
151. Andreani D, Menzinger G, Fallucca F, Aliberti G, Tamburrano G, Cassano C 1970 Insulin levels in thyrotoxicosis and primary myxoedema: response to intravenous glucose and glucagon. Diabetologia 6:1-7
152. Renauld A, Pinto JE, Sverdlik RC, Foglia VG 1971 Studies on the effects of hyperthyroidism on the insulin response to hyperglycemia in the dog. Horm Metab Res 3:247-251
153. Seino Y, Goto Y, Taminato T, Ikeda M, Imura H 1974 Plasma insulin and glucagon response to arginine in patients with thyroid dysfunction. J Clin Endocrinol Metab 38:1136-1140
154. Cavagnini F, Peracchi M, Raggi U, Bana R, Pontiroli AE, Malinverni A, Pinto M 1974 Impairment of growth hormone and insulin secretion in hyperthyroidism. Eur J Clin Invest 4:71-77
155. Lenzen S, Joost HG, Hasselblatt A 1976 Thyroid function and insulin secretion from the perfused pancreas in the rat. Endocrinology 99:125-129
156. Ahrén B, Lundquist I, Hedner P, Valdemarsson S, Scherstén B 1985 Glucose tolerance and insulin and C-peptide responses after various insulin secretion stimuli in hyper- and hypothyroid subjects before and after treatment. Diabetes Res 2:95-103 (Pubitemid 15039552)
157. Roti E, Braverman LE, Robuschi G, Salvi M, Gardini E, d'Amato L, Maestri D, Montermini M, Borciani E, Pezzarossa A 1986 Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide and glucagon in hyperthyroid patients. Metabolism 35:337-342 (Pubitemid 16079526)
158. Roubsanthisuk W, Watanakejorn P, Tunlakit M, Sriussadaporn S 2006 Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai 89(Suppl 5):S133-S140 (Pubitemid 46193142)
159. Holness MJ, Greenwood GK, Smith ND, Sugden MC 2008 PPARα activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism. Am J Physiol Endocrinol Metab 295:E1380-E1389
160. Doar JW, Stamp TC, Wynn V, Audhya TK 1969 Effects of oral and intravenous glucose loading in thyrotoxicosis: studies of plasma glucose, free fatty acids, plasma insulin and blood pyruvate levels. Diabetes 18:633-639
161. Marecek RL, Feldman JM 1973 Effect of hyperthyroidism on insulin and glucose dynamics in rabbits. Endocrinology 92:1604-1611
162. Andersen OO, Friis T, Ottesen B 1977 Glucose tolerance insulin secretion in hyperthyroidism. Acta Endocrinol 84:576-587 (Pubitemid 8043618)
163. Wajchenberg BL, Cesar FP, Leme CE, Souza IT, Pieroni RR, Mattar E 1978 Carbohydrate metabolism in thyrotoxicosis: studies on insulin secretion before and after remission from the hyperthyroid state. Horm Metab Res 10:294-299
164. Wahren J, Wennlund A, Nilsson LH, Felig P 1981 Influence of hyperthyroidism on splachnic exchange of glucose and gluconeogenesis precursors. J Clin Invest 67:1056-1063
165. Asano T, Okumura M 1982 Insulin delivery rates in response to glucose and arginine infusion in hyperthyroidism. Diabetologia 23:108-113
166. Osei K, Falko JM, O'Dorisio TM, Adam DR 1984 Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care 7:471-475
167. Shen DC, Davidson MB 1985 Hyperthyroid Graves' disease causes insulin antagonism. J Clin Endocrinol Metab 60:1038-1041
168. Jap TS, Ho LT, Won JG 1989 Insulin secretion and sensitivity in hyperthyroidism. Horm Metab Res 21:261-266
169. Al-Shoumer KA, Vasanthy BA, Al-Zaid MM 2006 Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 12:121-130
170. Ohguni S, Notsu K, Kato Y 1995 Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease. Intern Med 34:339-341
171. Gonzalo MA, Grant C, Moreno I, Garcia FJ, Suárez AI, Herrera-Pombo JL, Rovira A 1996 Glucose tolerance, insulin secretion, insulin sensitivity and glucose effectiveness in normal and overweight hyperthyroid women. Clin Endocrinol (Oxf) 45:689-697
172. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J 1992 Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29
173. Malaisse WJ, Malaisse-Lagae F, McCraw EF 1967 Effects of thyroid function upon insulin secretion. Diabetes 16:643-646
174. Lenzen S 1978 Dose-response studies on the inhibitory effect of thyroid hormones on insulin secretion in the rat. Metabolism 27:81-88 (Pubitemid 8262210)
175. Fukuchi M, Shimabukuro M, Shimajiri Y, Oshiro Y, Higa M, Akamine H, Komiya I, Takasu N 2002 Evidence for a deficient pancreatic β-cell response in a rat model of hyperthyroidism. Life Sci 71:1059-1070 (Pubitemid 34667108)
176. Dimitriadis G, Maratou E, Boutati E, Kollias A, Tsegka K, Alevizaki M, Peppa M, Raptis SA, Hadjidakis DJ 2008 IGF-1 increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Eur J Endocrinol 158:361-366 (Pubitemid 351405001)
177. Bech K, Damsbo P, Eldrup E, Beck-Nielsen H, Røder ME, Hartling SG, Vølund A, Madsbad S 1996 B-Cell function and glucose and lipid oxidation in Graves' disease. Clin Endocrinol (Oxf) 44:59-66 (Pubitemid 3019847)